Trademark Details For HEMO-TAP (Serial Number 73320360)

  •  Home
  •  Print
HEMO-TAP
0
0
0
0
Serial Number  United States - USPTO 73320360
Registration Number 1221539
Mark
HEMO-TAP
Filing Date Jul-23-1981
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0




010Medical apparatus

U.S Class(es): 044

Class Status: Active

First Use: Jan-1980

First Use in Commerce: Jan-1980





Correspondences

NameUTAH MEDICAL PRODUCTS, INC.
Address7043 SOUTH 300 WEST MIDVALE UT 84047

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Sep-21-1981ASSIGNED TO EXAMINER   DOCKD
Feb-02-1982ASSIGNED TO EXAMINER   DOCKD
Feb-23-1982APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Mar-09-1982NOTICE OF PUBLICATION   NPUBF
Nov-09-1982NOTICE OF PUBLICATION   NPUBO
Apr-20-1982PUBLISHED FOR OPPOSITION   PUBOA
Dec-28-1982REGISTERED-PRINCIPAL REGISTER   R.PRA
Sep-15-1988REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED   815FI
Nov-01-1988REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Jul-26-2002PAPER RECEIVED   MAILI
Jul-26-2002REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED   89AFI
Oct-18-2002REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Oct-18-2002REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Apr-16-2008CASE FILE IN TICRS   CFITO
Dec-12-2012PAPER RECEIVED   MAILI
Dec-12-2012REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED   89AFI
Jan-07-2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Jan-07-2013REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)   RNL2Q
Jan-07-2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED   NA89O
Apr-22-2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY   ASCKI
Jul-28-2022TEAS SECTION 8 & 9 RECEIVED   E89RI
Feb-13-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Feb-14-2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Feb-14-2023REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)   RNL3Q
Feb-14-2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E